SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

(Amendment No.     )

Adeza Biomedical Corporation

(Name of Issuer)

Common Stock

(Title of Class of Securities)

006990949

                                (CUSIP Number)                                 

December 31, 2004

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

CUSIP No. 006990949 13G Page 2 of 4 Pages

1.	NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON             Charlesbank Capital Partners, LLC
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)  ¨ (b)  ¨
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION             Massachusetts

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5.    SOLE VOTING POWER                 907,011 shares   6.    SHARED VOTING POWER                 —   7.    SOLE DISPOSITIVE POWER                 907,011 shares   8.    SHARED DISPOSITIVE POWER                 —

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON             907,011 shares
10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	¨
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)             5.7%
12.	TYPE OF REPORTING PERSON             OO

SCHEDULE 13G

Item 1	(a)	Name of Issuer:
		Adeza Biomedical Corporation
1	(b)	Address of Issuer’s Principal Executive Offices:
		1240 Elko Drive
		Sunnyvale, CA 94089
Item 2	(a)	Name of Person Filing:
		Charlesbank Capital Partners, LLC
2	(b)	Address of Principal Business Office or, if none, Residence:
		600 Atlantic Avenue, 26th Floor
		Boston, MA 02210
2	(c)	Citizenship:
		Massachusetts
2	(d)	Title of Class of Securities:
		Common Stock
2	(e)	CUSIP Number:     006990949
Item 3		Not applicable; the reporting person is filing pursuant to Rule 13d-1(d).
Item 4		Ownership:
4	(a)	Amount beneficially owned:     907,011 shares
4	(b)	Percent of Class:     5.7%
4	(c)	Number of shares as to which such person has:
		(i)	sole power to vote or to direct the vote:
			907,011 shares
		(ii)	shared power to vote or to direct the vote:
			_______________
		(iii)	sole power to dispose or to direct the disposition of:
			907,011 shares
		(iv)	shared power to dispose or to direct the disposition of:
			_______________

Page 3 of 4 Pages

Item 5	Ownership of Five Percent or Less of a Class:
	Not Applicable.
Item 6	Ownership of More than Five Percent on Behalf of Another Person:
	Pursuant to the Amended and Restated Existing Assets Management Agreement, dated September 30, 2001, between Charlesbank Capital Partners, LLC (“Charlesbank”), President and Fellows of Harvard College (“Harvard”) and certain individuals, Charlesbank acts as an investment manager on behalf of Harvard and its affiliates in connection with certain investments of Harvard and its affiliates, including the investment in Adeza Biomedical Corporation disclosed herein.
Item 7	Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company:
	Not Applicable.
Item 8	Identification and Classification of Members of the Group:
	Not Applicable.
Item 9	Notice of Dissolution of Group:
	Not Applicable.
Item 10	Certification:
	This certification is not required as the filing person is filing pursuant to 13d-1(d).

After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

CHARLESBANK CAPITAL PARTNERS, LLC
By:	/s/ Tami E. Nason
Name:	Tami E. Nason
Title:	Authorized Signatory

February 14, 2005

Page 4 of 4 Pages